Gong Tang

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang et al. · New England Journal of Medicine · 2004 · 6.4K citations · Full text

Medicine, Oncology, Breast Oncology +12

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Soonmyung Paik, Gong Tang, Steven Shak et al. · Journal of Clinical Oncology · 2006 · 2.6K citations

Medicine, Cancer Biology, Oncology +17

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

Eleftherios P. Mamounas, Gong Tang, Bernard Fisher et al. · Journal of Clinical Oncology · 2010 · 653 citations · Full text

Medicine, Oncology, Breast Oncology +14

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Harry D. Bear, Gong Tang, Priya Rastogi et al. · New England Journal of Medicine · 2012 · 469 citations · Full text

Medicine, Oncology, Pharmacology +13

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial

André Robidoux, Gong Tang, Priya Rastogi et al. · The Lancet Oncology · 2013 · 386 citations

Medicine, Oncology, Pharmacology +15